Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

188 results about "Bacterial vaginosis" patented technology

Overgrowth of bacteria in the vagina.

Methods for the diagnosis of bacterial vaginosis

The present invention relates to methods for the diagnosis of bacterial vaginosis based on an analysis of a patient sample. For example, patient test samples are analyzed for the presence or absence of one or more lactobacilli and two or more pathogenic organisms. The presence or absence of one or more lactobacilli and two or more pathogenic organisms may be detected using PCR analysis of nucleic acid segments corresponding to each target organism. The quantity of the target organisms can then be used to determine a score which is indicative of a diagnosis of bacterial vaginosis.
Owner:QUEST DIAGNOSTICS INVESTMENTS LLC

Gynaecologic multi-item dry chemical united detection test paper strip and its measuring method

The invention relates to a test paper tape which can be used in the gynecological multiprogramming dry-chemistry joint detection. The test paper tape provided by the utility model comprises a dry-chemistry multiprogramming detection test paper tape which consists of a plastic substrate tape and various solidified regent blocks, and sample diluent. The dry regent blocks include combinations formed by increasing or decreasing at least three or more regent blocks of a Ph test regent block, a lactic acid regent block, a hydrogen peroxide concentration regent block, a leukocyte esterase concentration regent block, a neuraminidase activity regent block, an amine test regent block, a proline aminopeptidase substrate reagent block, an oxidase substrate reagent block, a N-acetylamine hexosidase substrate reagent block, a trichomonas specific protease substrate hydrolysis reagent block. the gynecological multiprogramming dry-chemistry joint detection test paper test provided by the utility model can detect Ph, lactic acid, hydrogen peroxide, leukocyte esterase, neuraminidase, amine test, proline aminopeptidase, oxidase, N-acetylamine hexosidase and trichomonas specific protease which are contained in leucorrhea sample at the same time, and can accurately reflect the microorganism environment of a women reproductive tract, the cleanness of leucorrhea secretion and the conditions of Candida albicans, trichomonas, gonococcus and the pathogens of bacterial vaginosis, thereby making the gynecological trichomonas detection more comprehensive; besides, the test paper tape provided by the utility model can be used easily and conveniently, and results can be obtained quickly. If the test paper tape is used together with a gynecological dry-chemistry analyzer, the operation can become easier and the result can be obtained more quickly.
Owner:杭州健宝医疗器械有限公司

Diagnostic composition and article for monitoring intravaginal infections

The present invention provides a non-toxic diagnostic composition for intravaginal monitoring of vaginal infections. The present invention further provides a diagnostic article for intravaginal monitoring of vaginal infections with the article including an absorbent material for absorbing vaginal secretions and a composition suitable for identification of the pH or the buffer capacities associated with vaginal secretions. The diagnostic composition provides a visible indication of vaginal infections, such as bacterial vaginosis.
Owner:COMMON SENSE

Combined test kit for bacterial vagina disease

The invention provides the reagent box checking the bacterial vaginal disease, it includes the dry chemic reacting setting, the diluent and the liquid showing the color; the reacting setting has three blind holes placed the reagent mat testing the chroma of excessive oxidation hydrogen, the chroma of the leucocyte ester enzyme and the active ability of the saliva acid enzyme; the regent mat testing the chroma of the excessive oxidation hydrogen is dipped in the enzyme solution containing the peroxide enzyme, the phosphate amoritizing liquid, the 4-amino antipyrine, the 3,5-double chlorine double hydroxide group dobesilate and the vitamin C and dried. The reagent mat testing the chroma of the leucocyte ester enzyme is dipped in the enzyme solution containing the 5 bromine-4 chlorin- 3 heteroauxing salt and the cane suger and is dried; the reagent mat testing the active ability of the saliva acid enzyme is dipped in the 5 bromine-4 chlorin-3 indloe nerve arginine salt, the acetic acid salt cushioning liquid and the fucose and is dried; the cushioning liquid is composed of the physiological brine and MES cushioning liquid; the liquid showing the color is the B solution fixing the purple. The entironment, the cleanliness of the procreating path of the checked and the condition of the bug inducing the bacterial vagina can be test at the same time; it has many merits such as the easy handling, the celerity and the cheap cost.
Owner:北京中生金域诊断技术股份有限公司

Application of ratio of positive effects to negative effects in human microbial interaction network in assessment of human health and disease diagnosis

The invention relates to the fields of computational biology and medical health, and mainly aims at personalized precise diagnosis and health assessment of diseases called "microbial flora-related diseases", such as the disease of the digestive tract, bacterial vaginosis and periodontitis. An assessment method based on the microbial interaction network analysis of the human microbial flora is disclosed and validated. Specifically, the above diagnostic or assessment purpose is realized by detecting and monitoring the ratio of positive effects to negative effects in a human microbial interactionnetwork. By analyzing the microbial flora data of the human body including intestines, vagina, lungs, mouth and various parts of the skin, the inventor found that the ratio of positive effects to negative effects in the microbial interaction network of patients and that in the microbial interaction network of healthy people (ie, P/N ratio) are significantly different. Therefore, an effective detection index and implementation technology can be provided for personalized precise diagnosis of "microbial flora-related diseases", and at the same time, reliable reference indicators and technical support can be provided for assessing the disease risk of healthy people.
Owner:KUNMING INST OF ZOOLOGY CHINESE ACAD OF SCI

Lactobacillus crispatus and application thereof

The present invention discloses Lactobacillus crispatus 262-1 and an inoculum comprising such strain and application thereof. The Lactobacillus crispatus 262-1 is a new strain of Lactobacillus genus and is preserved in the China General Microbiological Culture Collection Center with a preservation number of CGMCC No. 6469. The Lactobacillus crispatus 262-1 particularly is the dominant bacteria in the vagina, has good acid and H2O2 production capability, good adhesion to the vaginal epithelial cells and significant resistance to bacterial vaginosis and various vaginal infections, and is characterized by safety, non-toxicity, good stability and long term preservation. The present invention also relates to the use of the Lactobacillus crispatus 262-1 in the preparation of pharmaceuticals for preventing and / or treating gynecological diseases and its application in feminine care products such as medical instruments, disinfect products or cosmetics.
Owner:SUZHOU OSEL BIO PHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products